Comparison of Large Language Models in Answering Immuno-Oncology Questions: A Cross-Sectional Study
This cross-sectional study assessed the ability of ChatGPT-4, ChatGPT-3.5, and Google Bard to answer questions related to immuno-oncology.
This cross-sectional study assessed the ability of ChatGPT-4, ChatGPT-3.5, and Google Bard to answer questions related to immuno-oncology.
Some doctors are promoting propellant-free inhalers over puff inhalers that emit greenhouse gases. Climate change can exacerbate respiratory ills because of more fires, air pollution…
AbstractAims. A major limitation of cardiac positron emission tomography (PET) with F18-fluorodeoxyglucose (F18-FDG) for the evaluation of cardiac sarcoido
FDA-AACR Workshop: How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases Date: May 9, 2024 | 9:00 a.m. – 4:00 p.m. Location:…
AbstractObjective. To improve the clinical utility of the Maintain High Blood Glucose subscale of the Hypoglycemia Fear Surveys (HFS) by identifying clinic
Mayo Clinic’s PragMMatic Study Accruing Newly Diagnosed Multiple Myeloma Patients A new clinical trial administered by the Mayo Clinic, the PragMMatic Study, is now accruing newly…
TPS9605 Background: Adjuvant treatment with anti-PD1 therapy improves the recurrence free survival (RFS) in resectable stage III melanoma. The Checkmate-238 and KEYNOTE-054 trials respectively reported…
FDA-AACR Workshop: How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases Date: May 9, 2024 | 9:00 a.m. – 4:00 p.m. Location:…
The OncoAlert Newsletter is now out for June 23-29, 2023
In a pair of Special Reports, Gökbuget and colleagues present updated European Leukemia Net (ELN) consensus reports on (1) the diagnosis, prognostic factor
‘Boring Milner’ and ‘Andy Robson’ accounts work with Fanwave Digital, a firm paid by Paddy Power Betfair to post betting tips